BindingDB logo
myBDB logout

BDBM165364 US9062043, Table 13, Compound 31::US9062043, Table 20b, Compound 22

SMILES: OC(=O)c1ccc2c(c1)nc(NCCc1cccc(F)c1)c1ccncc21

InChI Key: InChIKey=OGELIRNZSGROGB-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 165364   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Casein kinase II subunit alpha


(Homo sapiens (Human))
BDBM165364
PNG
(US9062043, Table 13, Compound 31 | US9062043, Tabl...)
Show SMILES OC(=O)c1ccc2c(c1)nc(NCCc1cccc(F)c1)c1ccncc21
Show InChI InChI=1S/C21H16FN3O2/c22-15-3-1-2-13(10-15)6-9-24-20-17-7-8-23-12-18(17)16-5-4-14(21(26)27)11-19(16)25-20/h1-5,7-8,10-12H,6,9H2,(H,24,25)(H,26,27)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
Purchase

PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 7n/an/an/an/a7.2n/a



SENHWA BIOSCIENCES, INC.

US Patent


Assay Description
Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (A...


US Patent US9062043 (2015)


BindingDB Entry DOI: 10.7270/Q20G3HWF
More data for this
Ligand-Target Pair
Casein kinase II subunit alpha


(Homo sapiens (Human))
BDBM165364
PNG
(US9062043, Table 13, Compound 31 | US9062043, Tabl...)
Show SMILES OC(=O)c1ccc2c(c1)nc(NCCc1cccc(F)c1)c1ccncc21
Show InChI InChI=1S/C21H16FN3O2/c22-15-3-1-2-13(10-15)6-9-24-20-17-7-8-23-12-18(17)16-5-4-14(21(26)27)11-19(16)25-20/h1-5,7-8,10-12H,6,9H2,(H,24,25)(H,26,27)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
Purchase

PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 3.60E+3n/an/an/an/a7.4n/a



SENHWA BIOSCIENCES, INC.

US Patent


Assay Description
The human leukemia Jurkat T-cell line was maintained in RPMI 1640 (Cambrex) supplemented with 10% fetal calf serum and 50 ng/ml Geutamycin. Before tr...


US Patent US9062043 (2015)


BindingDB Entry DOI: 10.7270/Q20G3HWF
More data for this
Ligand-Target Pair